Label Changes for:
Cordran (flurandrenolide, USP) Lotion
Changes have been made to the PRECAUTIONS and ADVERSE REACTIONS sections of the safety label.
Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) – July 2011
- Pediatric patients may absorb proportionately larger amounts.....
Information for Patients
- 2. Do not use Cordran Lotion on the face, underarms, or groin areas unless directed by your physician
Postmarketing Adverse Reactions
- The following adverse reactions have been identified during post approval use of flurandrenolide lotion. Because these reactions .....